Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer
Xuan Lin(Beijing Technology and Business University), Lina Liu(Guangxi University), Yun Wang(Sun Yat-sen University), Ying Xie(The First Hospital of Kunming), Xue Zhou(Huazhong University of Science and Technology), Zuquan Hu(Guiyang Medical University), Shichao Zhang(Second Hospital of Tianjin Medical University), Zhu Zeng(Guiyang Medical University), Jing Zhou(Peking University), Wei Qiu(Guiyang Medical University), Shiqi Long(Guiyang Medical University), Hedan Chen(Guiyang Medical University)
Cited by 30
Related Papers
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298
Emerging Epigenetic Regulation of Circular RNAs in Human Cancer
|Molecular Therapy — Nucleic Acids|2019|233
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
|The Journal of Immunology|2013|210
Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium
|Toxicology and Applied Pharmacology|2009|166
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients
|Scientific Reports|2021|143